|
IGF::OT::IGF CORE SUPPORT ACTIVITIES: SCIENTIFIC WRITING, TECHNICAL AND LOGISTICAL SUPPORT SERVICES
|
261201700004I
|
$1,200,000
|
|
BIZZELL, ANTON
|
-
|
|
Integrin Regulation of Cancer Progression Through Alternative mRNA Splicing and Nonsense-Medidated Decay (NMD)
|
5R01CA129637-08
|
$375,250
|
|
DIPERSIO, C MICHAEL
|
ALBANY MEDICAL COLLEGE
|
|
Signal transduction regulating tumor cell dissemination
|
5R01CA150344-30
|
$396,625
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
IGF::OT::IGF IGF::OF::IGF- PHASE III TRIAL OF CARBON ION THERAPY
|
261201500022C
|
$462,158
|
|
GUHA, CHANDAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Role of heat shock factors (Hsfs) in tumorigenesis
|
5R01CA132640-17
|
$270,000
|
|
MIVECHI, NAHID
|
AUGUSTA UNIVERSITY
|
|
DACH1/Eya Cell fate determination factor and mammary tumorigenesis
|
5R01CA132115-09
|
$428,056
|
|
PESTELL, RICHARD
|
BARUCH S. BLUMBERG INSTITUTE
|
|
SPORE in Lymphoma
|
1P50CA126752-01
|
$2,266,618
|
$906,647
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Ruxolitinib for Preventing Breast Cancer in Women on Neuroleptics
|
5R01CA205594-02
|
$362,569
|
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of PML nuclear body proteins for establishment of EBV latent infection
|
5R01CA124309-02
|
$258,530
|
$258,530
|
Ling, Paul
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
$30,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
$2,234
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel Strategies for Immunotherapy fo Cancer
|
5R01CA101795-04
|
$263,284
|
$263,284
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Effects of High Fructose Corn Syrup on Intestinal Tumorigenesis
|
1K22CA216036-01
|
$179,877
|
|
YUN, JIHYE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Reolysin-based combination therapy in relapsed multiple myeloma
|
5R01CA194742-03
|
$574,645
|
|
PICHIORRI, FLAVIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Modeling KRAS genetic heterogeneity in mouse models
|
5R01CA195744-03
|
$635,205
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
MiR-199~214 cluster at the crossroads of plasticity and malignancy in breastcancer
|
5R01CA207322-02
|
$395,738
|
|
KARNOUB, ANTOINE
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Immediate Early Genes of Herpes Simplex Virus
|
5R01CA020260-31
|
$432,063
|
$432,063
|
SCHAFFER, PRISCILLA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Passive and active targeting of unnatural chemokine fusions for cancer immunotherapies
|
1F32CA220990-01
|
$61,174
|
|
FANG, TAO
|
BOSTON CHILDREN'S HOSPITAL
|
|
Regulation of the LIN28/let-7 pathway in cancer
|
5R01CA211328-02
|
$404,888
|
|
GREGORY, RICHARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Development of diagnostic and prognostic tests for esophageal adenocarcinoma
|
5R01CA208599-02
|
$603,464
|
|
GODFREY, TONY
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Evaluating mass spectrometry for intraoperative tissue characterization in breast-conserving therapy
|
5R01CA201469-03
|
$406,031
|
|
AGAR, NATHALIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Elucidating the Regulation and Function of the NF1 tumor suppressor
|
5R01CA111754-13
|
$316,635
|
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
How does malignancy subvert platelet and megakaryocytic biology?
|
5R01CA200748-02
|
$550,945
|
|
ITALIANO, JOSEPH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
3R01CA082036-08S1
|
$66,889
|
$66,889
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
5R01CA082036-08
|
$373,347
|
$373,347
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation
|
2R01CA047006-20A2
|
$538,386
|
$538,386
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus LMP-1 Mediated Oncongenicity
|
5R01CA085180-07
|
$744,728
|
$744,728
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis of Epstein-Barr Virus Infection
|
5R01CA068051-12
|
$403,843
|
$403,843
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Natural Killer Cell Growth and Development
|
5R01CA041268-22
|
$337,399
|
$168,700
|
BIRON, CHRISTINE
|
BROWN UNIVERSITY
|
|
Key Innate Mechanisms of Natural Killer Cell Trafficking
|
5R01CA102708-05
|
$239,867
|
$239,867
|
SALAZAR-MATHER, THAIS
|
BROWN UNIVERSITY
|
|
Regulatory Support for Cancer Prevention Agent Development
|
261201800017C
|
$2,653,402
|
|
-, -
|
CCS ASSOCIATES, INC.
|
|
Technical Information Research Resources for Cancer Preventive Agent Development
|
261201800030C
|
$2,219,906
|
|
-, -
|
CCS ASSOCIATES, INC.
|
|
NCHS: NHIS CANCER CONTROL SUPPLEMENT PARTNERSHIP WITH NCI/DCCPS/HDRP
|
APC18005-001
|
$2,000,000
|
|
-, -
|
CENTERS FOR DISEASE CONTROL &
|
|
NATIONAL HEALTH AND NUTRITION EXAM SURVEY
|
APC18007-001
|
$50,000
|
|
-, -
|
CENTERS FOR DISEASE CONTROL &
|
|
SEER-MHOS REVIEW AND TECHNICAL ASSISTANCE
|
APC16004-001
|
$150,000
|
|
-, -
|
CENTERS FOR MEDICARE & MEDICAI
|
|
The role of H3K79 methylation in IDH-mutant leukemia
|
5R01CA201230-04
|
$438,616
|
|
BERNT, KATHRIN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Peptide Vaccine To Prevent CMV Disease After HSCT
|
3R01CA077544-09S1
|
$107,242
|
$107,242
|
Diamond, Don
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Peptide Vaccine To Prevent CMV Disease After HSCT
|
5R01CA077544-09
|
$466,660
|
$466,660
|
Diamond, Don
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA033572-24S1
|
$61,920
|
$2,477
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA033572-24S2
|
$103,852
|
$4,154
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA033572-24
|
$2,274,248
|
$90,970
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Molecular mechanisms of prostate cancer metastasis
|
5R01CA183929-04
|
$366,000
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
AIDS Associated Lymphoproliferative Disorders
|
4R37CA037295-24
|
$402,500
|
$161,000
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Fusobacterium nucleatum-mediated stimulation of colorectal cancer: mechanistic studies
|
5R01CA192111-04
|
$420,608
|
|
HAN, YIPING
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of ATM in Suppression of Lymphomas
|
5R01CA158073-07
|
$380,000
|
|
ZHA, SHAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Surveillance, Epidemiology, and End Results (SEER) Program
|
261201800002I
|
$2,780,671
|
|
-, -
|
CONNECTICUT STATE DEPT OF PUBLIC HEALTH
|
|
ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping
|
5R44CA210820-02
|
$989,401
|
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
Genotype and Imaging Phenotype Biomarkers in Lung Cancer
|
5U01CA190234-04
|
$659,886
|
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Defining the impact of clonal evolution on chronic lymphocytic leukemia
|
5R01CA182461-05
|
$362,378
|
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
$3,736
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
Total relevant funding to Herpes - Other for this search: $50,627,794
|